NCT07523282 Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases Status NOT_YET_RECRUITING Phase PHASE1
NCT07517536 CHT105 for the Treatment of Refractory Lupus Nephritis Status ENROLLING_BY_INVITATION Phase NA
NCT07515014 A Study of E6742 in Participants With Systemic Lupus Erythematosus Status RECRUITING Phase PHASE2
NCT07509892 A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus Erythematosus Status RECRUITING Phase PHASE2
NCT07493655 Therapeutic Drug Monitoring of Mycophenolate Mofetil in Lupus Nephritis Status NOT_YET_RECRUITING Phase NA
NCT07430306 A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus Status RECRUITING Phase PHASE3
NCT07410377 UCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune Diseases Status WITHDRAWN Phase EARLY_PHASE1
NCT07409181 A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE) Status RECRUITING Phase PHASE2
NCT07408908 Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants.. Status NOT_YET_RECRUITING Phase PHASE1
NCT07405970 A Phase 3 Clinical Study of MIL62 in Systemic Lupus Erythematosus Status RECRUITING Phase PHASE3
NCT07397728 " TREX1 Gene Mutations and Their Role in Systemic Lupus Erythematosus Status RECRUITING Phase N/A
NCT07371468 A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD) Status RECRUITING Phase PHASE1
NCT07363590 A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) Status RECRUITING Phase PHASE1
NCT07323173 A Phase I Study to Assess LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus Status RECRUITING Phase PHASE1
NCT07318259 Study of Ultra-Fast BCMA/CD70 CAR-T Therapy for Refractory SLE Status RECRUITING Phase PHASE1
NCT07299422 A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus Status RECRUITING Phase PHASE2